Your browser is no longer supported. Please, upgrade your browser.
Settings
HSGX Histogenics Corporation daily Stock Chart
HSGX [NASD]
Histogenics Corporation
Index- P/E1.87 EPS (ttm)0.11 Insider Own6.00% Shs Outstand96.50M Perf Week-0.05%
Market Cap19.29M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float88.50M Perf Month-2.49%
Income-3.50M PEG- EPS next Q- Inst Own12.90% Short Float5.10% Perf Quarter3.04%
Sales- P/S- EPS this Y76.40% Inst Trans- Short Ratio0.61 Perf Half Y29.22%
Book/sh-0.07 P/B- EPS next Y- ROA- Target Price5.00 Perf Year-91.67%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range0.08 - 3.00 Perf YTD126.13%
Dividend- P/FCF- EPS past 5Y38.20% ROI- 52W High-93.60% Beta3.30
Dividend %- Quick Ratio3.50 Sales past 5Y- Gross Margin- 52W Low140.00% ATR0.02
Employees49 Current Ratio3.50 Sales Q/Q- Oper. Margin- RSI (14)45.56 Volatility6.38% 7.63%
OptionableNo Debt/Eq- EPS Q/Q77.00% Profit Margin- Rel Volume0.65 Prev Close0.20
ShortableYes LT Debt/Eq- EarningsAug 14 BMO Payout- Avg Volume7.44M Price0.19
Recom3.00 SMA20-3.67% SMA50-3.91% SMA200-31.78% Volume1,715,370 Change-3.95%
Dec-19-16Initiated H.C. Wainwright Buy $3.50
Sep-19-16Reiterated Needham Buy $11 → $8
Nov-13-15Reiterated Needham Buy $17 → $15
Nov-13-15Reiterated Canaccord Genuity Buy $15 → $8
Jan-05-15Initiated Needham Buy $17
Jan-05-15Initiated Canaccord Genuity Buy $16.50
Apr-30-19 08:00AM  How Will Histogenics Shareholders Fare in the Merger with Ocugen ACCESSWIRE
Apr-08-19 05:50PM  Histogenics News: Why Did HSGX Stock Soar Today? InvestorPlace +56.00%
12:48PM  Ocular Biotechs Histogenics, Ocugen Announce Stock-For-Stock Merger Benzinga
09:58AM  Histogenics to serve as shell for Pennsylvania biotech in reverse-merger American City Business Journals
09:33AM  Malvern gene therapy developer to acquire publicly traded Boston company American City Business Journals
07:00AM  Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics GlobeNewswire
Mar-25-19 05:44AM  Edited Transcript of HSGX earnings conference call or presentation 9-Nov-17 1:30pm GMT Thomson Reuters StreetEvents
Feb-20-19 08:00AM  Biotech Bounce Just Getting Started ACCESSWIRE
Feb-12-19 08:00AM  Jonathan Lieber Joins Danforth Advisors as Managing Director GlobeNewswire
Jan-31-19 08:00AM  Biotech Stocks on the Rise ACCESSWIRE +50.72%
Jan-28-19 09:30AM  Is Histogenics (HSGX) Outperforming Other Medical Stocks This Year? Zacks
Jan-23-19 08:30AM  Best Ways to Play Biotech Rally ACCESSWIRE
Jan-08-19 08:30AM  The Next Big Biotech Breakout ACCESSWIRE -10.15%
Jan-04-19 08:50AM  4 Healthcare Stocks To Watch On Friday (1/4/19) ACCESSWIRE +22.01%
Dec-21-18 04:05PM  Histogenics and FDA Conclude Discussions Regarding NeoCart® Phase 3 Clinical Trial Data and Regulatory Pathway GlobeNewswire
Nov-29-18 08:30AM  Histogenics and FDA Continue to Discuss NeoCart® Phase 3 Clinical Trial Data and Potential Regulatory Pathway GlobeNewswire -12.06%
Nov-23-18 07:50AM  New Research Coverage Highlights Intersections, PRGX Global, Ecology and Environment, Histogenics, SeaChange International, and TransAct Technologies Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-12-18 06:10AM  Cell therapy biotech Vericel eyes $2B knee repair market American City Business Journals -6.71%
Nov-08-18 07:07AM  Histogenics: 3Q Earnings Snapshot Associated Press
06:30AM  Histogenics Corporation Announces Third Quarter 2018 Financial and Operating Results GlobeNewswire
Nov-01-18 04:05PM  Histogenics and FDA to Continue Discussions on NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway GlobeNewswire
Oct-25-18 04:15PM  Histogenics Corporation to Report Third Quarter 2018 Financial Results on November 8, 2018 GlobeNewswire +5.69%
Oct-24-18 08:15AM  What is Next for Histogenics, Pending FDA Meeting and Analysts Target Price ACCESSWIRE
Oct-15-18 08:00AM  Todays Research Reports on Stocks to Watch: Immune Design and Histogenics ACCESSWIRE +11.43%
Oct-10-18 04:01PM  Histogenics Corporation Announces Closing of Public Offering of Common Stock and Warrants GlobeNewswire -7.14%
Oct-05-18 08:10AM  Histogenics Corporation Announces Pricing of Public Offering of Common Stock and Warrants GlobeNewswire -39.60%
Oct-04-18 04:01PM  Histogenics Corporation Announces Proposed Public Offering of Common Stock and Warrants GlobeNewswire +51.52%
Sep-26-18 04:05PM  Histogenics to Meet With FDA to Discuss NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway GlobeNewswire
Sep-05-18 12:04PM  Histogenics Slips Below $1 Threshold After Knee Cartilage Candidate Fails Late-Stage Study Benzinga -72.56%
11:56AM  Histogenics to seek FDA approval for cell therapy despite failed study American City Business Journals
05:00AM  Histogenics Announces Top-Line Results From Phase 3 Clinical Trial of NeoCart® in Patients With Knee Cartilage Damage GlobeNewswire
Aug-10-18 08:40PM  Edited Transcript of HSGX earnings conference call or presentation 9-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
05:08AM  Histogenics Sees Hammer Chart Pattern: Time to Buy? Zacks
Aug-09-18 06:49AM  Histogenics: 2Q Earnings Snapshot Associated Press
06:30AM  Histogenics Corporation Announces Second Quarter 2018 Financial and Operating Results GlobeNewswire
06:30AM  Histogenics Corp. to Host Earnings Call ACCESSWIRE
Jul-31-18 08:00AM  Histogenics Corporation Appoints E. Lynne Kelley, M.D., FACS As Chief Medical Officer GlobeNewswire
Jul-26-18 08:30AM  Histogenics Corporation to Report Second Quarter 2018 Financial Results on August 9, 2018 GlobeNewswire -6.87%
Jul-25-18 04:15PM  Histogenics Corporation to Present at Canaccord Genuitys 38th Annual Growth Conference GlobeNewswire
Jul-23-18 08:30AM  Histogenics Chief Operating Officer, Stephen Kennedy Appointed to Advanced Regenerative Manufacturing Institutes Technology Advisory Sub-Committee GlobeNewswire
May-31-18 08:30AM  Histogenics Corporation to Host Investor Day on June 19, 2018 GlobeNewswire
May-14-18 08:48PM  Edited Transcript of HSGX earnings conference call or presentation 10-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-10-18 06:39AM  Histogenics: 1Q Earnings Snapshot Associated Press
06:30AM  Histogenics Corporation Announces First Quarter 2018 Financial and Operating Results GlobeNewswire
Apr-26-18 08:30AM  Histogenics Corporation to Report First Quarter 2018 Financial Results on May 10, 2018 GlobeNewswire
Apr-18-18 03:49PM  How Do Analysts See Histogenics Corporation (NASDAQ:HSGX) Performing Over The Next Few Years? Simply Wall St.
08:30AM  Histogenics Corporation Announces the Appointment of Susan Washer to Its Board of Directors GlobeNewswire
Mar-28-18 08:30AM  Histogenics Corporation to Present at Upcoming Investor Conferences GlobeNewswire
Mar-19-18 08:30AM  Histogenics Corporation to Present at Needham & Companys 17th Annual Healthcare Conference GlobeNewswire
Mar-16-18 08:32PM  Edited Transcript of HSGX earnings conference call or presentation 15-Mar-18 12:30pm GMT Thomson Reuters StreetEvents
Mar-15-18 06:40AM  Histogenics Corp. to Host Earnings Call ACCESSWIRE
06:35AM  Histogenics reports 4Q loss Associated Press
06:00AM  Histogenics Corporation Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2017 GlobeNewswire
Mar-02-18 08:30AM  Histogenics to Showcase NeoCart® at American Academy of Orthopedic Surgeons and Orthopedic Research Society 2018 Annual Meetings GlobeNewswire
Mar-01-18 08:30AM  Histogenics Corporation to Report 2017 Financial Results on March 15, 2018 GlobeNewswire
Feb-22-18 04:23PM  Histogenics Corporation (NASDAQ:HSGX): Is Healthcare Attractive Relative To NasdaqCM Peers? Simply Wall St.
Feb-20-18 08:30AM  Histogenics Corporation to Present at Upcoming Investor Conferences GlobeNewswire
Jan-25-18 04:05PM  Histogenics Corporation Announces Closing of Underwritten Registered Direct Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Jan-22-18 06:59PM  Histogenics Corporation Announces Pricing of Underwritten Registered Direct Offering of 2,340,430 Shares of Common Stock GlobeNewswire
Jan-10-18 09:52AM  What Should You Know About Histogenics Corporations (NASDAQ:HSGX) Earnings Trajectory? Simply Wall St. +7.72%
Jan-09-18 08:30AM  Histogenics Corporation Announces Receipt of $10 Million Up-front Payment for Japanese Neocart Agreement GlobeNewswire +9.82%
Dec-21-17 06:00AM  Histogenics Corporation and MEDINET Co., Ltd Enter Into Licensing Agreement for Development and Commercialization of NeoCart for the Japanese Market GlobeNewswire +18.39%
Dec-15-17 11:05AM  Interested In Histogenics Corporation (NASDAQ:HSGX)? Heres What Its Recent Track-Record Looks Like Simply Wall St.
Nov-09-17 08:52AM  Histogenics reports 3Q loss Associated Press
06:30AM  Histogenics Corporation Announces Third Quarter 2017 Financial and Operating Results GlobeNewswire
Oct-27-17 04:21PM  Histogenics Corporation (HSGX): Time For A Financial Health Check Simply Wall St.
Oct-26-17 08:30AM  Histogenics Corporation to Report Third Quarter 2017 Financial Results on November 9, 2017 GlobeNewswire
Oct-12-17 09:00AM  Histogenics Corporation Promotes Stephen Kennedy to Executive Vice President & Chief Operating Officer GlobeNewswire +8.88%
Oct-02-17 04:15PM  Histogenics Announces Publication of Additional Biomechanical Data From Human Engineered Cartilage Testing GlobeNewswire
Sep-26-17 08:30AM  Histogenics Corporation to Present at the 2017 Cell & Gene Meeting on the Mesa GlobeNewswire
Sep-13-17 04:55PM  How Should You Think About Histogenics Corporations (HSGX) Risks? Simply Wall St.
Aug-24-17 08:30AM  Histogenics Corporation to Present at Upcoming Investor Conferences GlobeNewswire
Aug-11-17 01:30PM  Edited Transcript of HSGX earnings conference call or presentation 10-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-10-17 09:41PM  Histogenics reports 2Q loss Associated Press
06:30AM  Investor Network: Histogenics Corp. to Host Earnings Call ACCESSWIRE
06:30AM  Histogenics Corporation Announces Second Quarter 2017 Financial and Operating Results GlobeNewswire
Jul-27-17 08:30AM  Histogenics Corporation to Announce Second Quarter 2017 Financial Results on August 10, 2017 GlobeNewswire
Jul-26-17 08:30AM  Histogenics Corporation to Present at the 37th Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-11-17 08:30AM  Histogenics Announces Publication of Data From Collagen and Chondrocyte 3-D Bioprinting Study GlobeNewswire
Jun-27-17 04:01PM  Histogenics Completes Enrollment for Phase 3 Clinical Trial of Neocart® to Treat Knee Cartilage Damage GlobeNewswire
Jun-22-17 09:30AM  The Zacks Analyst Blog Highlights: Cambrex, Geron, Anavex Life Sciences and Histogenics Zacks
Jun-21-17 09:52AM  Fresh Capital to Be Injected into Biotech Stocks: 5 Must-Buys Zacks
Jun-05-17 08:30AM  Histogenics Corporation Announces the Appointment of Donald Haut, Ph.D. as Chief Business Officer GlobeNewswire
May-19-17 09:00AM  Edited Transcript of HSGX earnings conference call or presentation 11-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-16-17 08:30AM  Histogenics Corporation to Present at Upcoming Industry Conferences GlobeNewswire
May-15-17 08:30AM  Histogenics Corporation Receives Innovation Award GlobeNewswire
May-11-17 07:30AM  Investor Network: Histogenics Corp. to Host Earnings Call Accesswire
06:44AM  Histogenics reports 1Q loss Associated Press
06:30AM  Histogenics Corporation Announces First Quarter 2017 Financial and Operating Results GlobeNewswire
May-08-17 06:30AM  Histogenics Announces Agreement With the Japan Pharmaceuticals and Medical Devices Agency Regarding Japanese Regulatory Pathway for NeoCart® GlobeNewswire
Apr-27-17 08:30AM  Histogenics Corporation To Announce First Quarter 2017 Financial Results on May 11, 2017 GlobeNewswire
Apr-24-17 04:15PM  Histogenics Corporation to Present at 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017 GlobeNewswire
Mar-29-17 08:30AM  Histogenics Corporation to Present at Needham & Companys 16th Annual Healthcare Conference GlobeNewswire
Mar-27-17 04:07PM  HISTOGENICS CORP Files SEC form 8-K, Other Events
Mar-23-17 01:04PM  HISTOGENICS CORP Financials
Mar-17-17 09:35AM  Edited Transcript of HSGX earnings conference call or presentation 16-Mar-17 12:30pm GMT Thomson Reuters StreetEvents
Mar-16-17 09:37AM  Histogenics posts 4Q profit Associated Press
08:30AM  Histogenics Corp Earnings Call scheduled for 8:30 am ET today
07:32AM  HISTOGENICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:07AM  Q4 2016 Histogenics Corp Earnings Release - Before Market Open
Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIRK RANDAL J10% OwnerJan 15Sale0.15345,89751,8851,692,366Jan 15 05:21 PM
KIRK RANDAL J10% OwnerJan 14Sale0.16400,50764,0812,038,263Jan 15 05:21 PM
KIRK RANDAL J10% OwnerJan 11Sale0.17251,80042,8062,438,770Jan 15 05:21 PM